Ethinylestradiol/norelgestromin

Ethinylestradiol/norelgestromin (brand names Ortho Evra, Evra, Xulane) is a contraceptive patch containing the estrogen ethinylestradiol and the progestin norelgestromin which is marketed in the United States, Canada, Europe, and elsewhere in the world.[1] As of December 2016, the product Ortho Evra has been discontinued in the U.S. while the product Xulane continues to be marketed. [1]

Ethinylestradiol/norelgestromin
Combination of
EthinylestradiolEstrogen
NorelgestrominProgestogen
Clinical data
Trade namesOrtho Evra, Xulane
MedlinePlusa602006
License data
Pregnancy
category
  • US: X (Contraindicated)
    Routes of
    administration    		Transdermal (patch)
    Legal status
    Legal status
    Identifiers
    CAS Number
    PubChem CID
    ChemSpider
    • None
    KEGG
    Main article: Contraceptive patch

    See also

    References
    1. "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 22 December 2016.


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.